Latest news
Loading news…
Cardioxyl Pharmaceuticals discovers, develops and commercializes therapies for the treatment of cardiovascular disease.
Cardioxyl Pharmaceuticals was acquired by Bristol-Myers Squibb in 2015 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Chapel Hill, North Carolina, United States
Key People at Cardioxyl Pharmaceuticals
Scientific Co-Founder
President and CEO
1
professional contacts at Cardioxyl Pharmaceuticals
Contact execs at Cardioxyl Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Cardioxyl Pharmaceuticals
Loading news…
FAQs about Cardioxyl Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.